Skip to content
10-Q

Quarterly Report

PEAK PHARMACEUTICALS, INC. RMHI

0001199835-22-000826

← back to feed
Filed
Dec 19, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q2 2021 · Mar 31, 2021 −$60
Stockholders Equity Q2 2021 · Mar 31, 2021 −$300.16K
Stockholders Equity Q2 2021 · Dec 31, 2020 −$257.45K
Stockholders Equity Q2 2021 · Sep 30, 2020 −$250.1K
Current Liabilities Q2 2021 · Mar 31, 2021 $300.51K
Current Liabilities Q2 2021 · Sep 30, 2020 $250.5K
Total Liabilities Q2 2021 · Mar 31, 2021 $300.51K
Total Liabilities Q2 2021 · Sep 30, 2020 $250.5K
Current Assets Q2 2021 · Mar 31, 2021 $348
Current Assets Q2 2021 · Sep 30, 2020 $408
Total Assets Q2 2021 · Mar 31, 2021 $348
Total Assets Q2 2021 · Sep 30, 2020 $408
Net Income Q2 2021 · Mar 31, 2021 −$42.71K
Net Income Q2 2021 · Mar 31, 2021 −$50.07K
Net Income Q2 2021 · Dec 31, 2020 −$7.35K
Operating Income Q2 2021 · Mar 31, 2021 −$48.22K
Operating Income Q2 2021 · Mar 31, 2020 −$1.17K